Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
THERAVANCE BIOPHARMA INC
Ticker: TBPH
CUSIP: G8807B106
Class: Common Stock
Bleakley Financial Group, LLC's Holding History (CIK: 0001936953)
Note: Option positions (PUT/CALL) are excluded.
Q4 2023
Shares
12,584
Value ($000)
$141
Avg Close
$10.06
Range
$8.52 - $11.57
Q2 2023
Shares
23,700
Value ($000)
$245
Avg Close
$11.04
Range
$9.98 - $12.03
Period
Shares
Value ($000)
Average Close
Price Range
Q4 2023
12,584
$141
$10.06
$8.52 - $11.57
Q2 2023
23,700
$245
$11.04
$9.98 - $12.03